Policies, Protocols & Procedures
This document is the School Authority Letter for 2022-2023 and is a part of the New Mexico Childcare/Pre-School/School Entry Immunization Requirements.
This protocol provides direction for implementing and incorporating syringe services into the spectrum of prevention health services offered by the Department of Health.
This is the Protocol and Standing Orders for Public Health Nurses and Staff with Current Certification to conduct Rapid Testing for the Hepatitis C Virus (HCV) using the Oraquick® Test Device.
This is for nurses and Department of Health staff who conduct community and offsite vaccination outreach clinics.
This is part of the family planning protocol document series.
This is part of the family planning protocol document series.
This is part of the family planning protocol document series.
This is part of the family planning protocol document series.
This is part of the family planning protocol document series.
Explains how to submit a petition to the medical cannabis advisory board.
This is the document which outlines the protocol (procedures) required to be followed by New Mexico Department of Health staff providing overdose prevention and naloxone distribution services.
This protocol is intended to ensure two-way communication between PHOs and pharmaceutical representatives, while simultaneously allowing programmatic staff to effectively maintain the complexity of being a universal vaccine state, providing choice and ensuring no single vaccine and/or manufacturer is favored over one or the other.
The guidelines in this document were developed to help hospitals establish policies and standing orders in their labor and delivery and newborn units to Prevent Hepatitis B Virus Transmission.
This is our official notice of nondiscrimination.
Statewide standing order of Naloxone in schools.
To contribute to decreasing morbidity and mortality related to opioid overdose, this standing order permits clinical staff of registered overdose prevention and education programs to obtain, store, and dispense/distribute naloxone to eligible clients; and non-clinical staff and volunteers who have completed the hepatitis and harm reduction certification training to obtain, store and distribute naloxone to eligible clients.
This document describes what notifiable conditions and diseases must be reports and provides details regarding what information must be included in the notification. It also provides time frames and contact information to help make reporting easy.
This memo informs all air and ground medical agencies that there are new designated air to ground frequencies as of July 11, 2016. If your agency is to use these frequencies this document must be posted within your operations center.
This is part of the family planning protocol document series.